on 15 Dec 2022
Last Applicant/ Owned by
2906 Frederick Douglass Blvd.
New York
NY
10039
Serial Number
97110806 filed on 05th Nov 2021
Registration Number
N/A
Correspondent Address
FREDERICK S. HUNTER
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"FARMS"
Natural plants and flowers other than the Neoregelia plant; plant seeds from plants other than the Neoregelia plant; none of the foregoing containing any CBD; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis "FARMS" Fruit juice; bottled water not fortified; none of the foregoing containRead More
Ashtrays; lighters for smokers; Hemp cigarettes, with THC less than 0.3 percent dry weight; Cigarettes containing tobacco substitutes, not for medical purposes; Tobacco grinders; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Fruit juice; bottled water not fortified; none of the foregoing containing any CBD; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Natural plants and flowers other than the Neoregelia plant; plant seeds from plants other than the Neoregelia plant; none of the foregoing containing any CBD; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Candy, candy bars, chocolate truffles; none of the foregoing containing any CBD; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Tops as clothing; Bottoms as clothing; Headwear; Hats
Plant extracts for pharmaceutical purposes other than plant extracts from the Neoregelia plant; hemostatics for medical purposes; pharmaceuticals, namely, pharmaceuticals for the treatment of nausea, anxiety, pain, glaucoma, seizures, multiple sclerosis and Crohn's Disease; none of the foregoing containing any CBD; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
No 97110806
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 15th Dec 2022 | OPPOSITION INSTITUTED NO. 999999 |
| 15th Sep 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 15th Sep 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| 15th Sep 2022 | WITHDRAWAL OF ATTORNEY GRANTED |
| 16th Aug 2022 | PUBLISHED FOR OPPOSITION |
| 16th Aug 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Jul 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 08th Jul 2022 | EXAMINERS AMENDMENT -WRITTEN |
| 08th Jul 2022 | EXAMINERS AMENDMENT E-MAILED |
| 08th Jul 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
